Omega Therapeutics, Inc. (NASDAQ:OMGA – Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 1,630,000 shares, a growth of 15.6% from the June 30th total of 1,410,000 shares. Approximately 7.6% of the company’s stock are short sold. […]